tradingkey.logo
tradingkey.logo
Search

AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly

ReutersApr 7, 2026 11:13 AM

- AC Immune SA ACIU.O:

  • AC IMMUNE ANNOUNCES AMENDMENT TO MORPHOMER ® TAU LICENSE AND COLLABORATION AGREEMENT WITH LILLY

  • AC IMMUNE SA - IND-ENABLING STUDIES TO COMMENCE IN H1 2026

  • AC IMMUNE SA - AMENDED AGREEMENT COVERS DEVELOPMENT OF NEW TAU MORPHOMER CANDIDATES

  • AC IMMUNE SA - UNDER AMENDMENT, CO TO RECEIVE CHF10 MILLION UPFRONT PAYMENT AND PHASE 1 MILESTONE PAYMENT

  • AC IMMUNE SA - ELIGIBLE FOR OVER CHF1.7 BILLION IN MILESTONES PLUS TIERED ROYALTIES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI